- Home
- PRME vs BSX Comparison
PRME vs BSX Comparison
Compare PRME & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- BSX
- Stock Information
- Founded
- PRME 2019
- BSX 1979
- Country
- PRME United States
- BSX United States
- Employees
- PRME N/A
- BSX N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- BSX Medical/Dental Instruments
- Sector
- PRME Health Care
- BSX Health Care
- Exchange
- PRME Nasdaq
- BSX Nasdaq
- Market Cap
- PRME N/A
- BSX 138.5B
- IPO Year
- PRME 2022
- BSX 1992
- Fundamental
- Price
- PRME $1.69
- BSX $101.91
- Analyst Decision
- PRME Strong Buy
- BSX Strong Buy
- Analyst Count
- PRME 8
- BSX 23
- Target Price
- PRME $13.25
- BSX $110.57
- AVG Volume (30 Days)
- PRME 1.8M
- BSX 10.5M
- Earning Date
- PRME 05-09-2025
- BSX 04-23-2025
- Dividend Yield
- PRME N/A
- BSX N/A
- EPS Growth
- PRME N/A
- BSX 15.23
- EPS
- PRME N/A
- BSX 1.37
- Revenue
- PRME $2,983,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- PRME $56.92
- BSX $15.77
- Revenue Next Year
- PRME $150.59
- BSX $10.33
- P/E Ratio
- PRME N/A
- BSX $74.36
- Revenue Growth
- PRME N/A
- BSX 19.36
- 52 Week Low
- PRME $1.12
- BSX $70.97
- 52 Week High
- PRME $8.27
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- PRME 51.39
- BSX 59.77
- Support Level
- PRME $1.20
- BSX $92.70
- Resistance Level
- PRME $1.86
- BSX $102.37
- Average True Range (ATR)
- PRME 0.18
- BSX 3.73
- MACD
- PRME 0.08
- BSX 0.98
- Stochastic Oscillator
- PRME 77.18
- BSX 97.19
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.